Classification of gadolinium-based contrast agents (GBCAs)-adverse reactions

被引：5
作者：
Boehm, Ingrid B. [1 ]
机构：
[1] Univ Bern, Inselspital, Dept Diagnost Intervent & Pediat Radiol, Freiburgstr, CH-3010 Bern, Switzerland
来源：
MAGNETIC RESONANCE IMAGING | 2022年 / 85卷
关键词：
Hypersensitivity reactions; Immediate reactions; Non-immediate (delayed) reactions; Gadolinium deposition disease; Gadolinium storage condition; Nephrogenic systemic fibrosis; Gadolinium deposits; Allergy; Non-allergy; Type A reactions; Type B reactions;
D O I：
10.1016/j.mri.2021.10.006
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：1 / 2
页数：2
相关论文
共 50 条
  • [31] Caution in Using Gadolinium-Based Contrast Agents in Interventional Pain Procedures
    Benzon, Honorio T.
    Liu, Benjamin P.
    Patel, Arpan
    Benzon, Hubert A.
    ANESTHESIA AND ANALGESIA, 2018, 127 (06) : 1452 - 1456
  • [32] Gadolinium-Based Contrast Agents and NSF: Evidence from Animal Experience
    Sieber, Martin A.
    Steger-Hartmann, Thomas
    Lengsfeld, Philipp
    Pietsch, Hubertus
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2009, 30 (06) : 1268 - 1276
  • [33] Divalent Manganese Complexes as Potential Replacements for Gadolinium-Based Contrast Agents
    Caravan, Peter
    INVESTIGATIVE RADIOLOGY, 2024, 59 (02) : 187 - 196
  • [34] Effects of gadolinium-based contrast agents on submandibular gland tissue in rats
    Celiker, Fatma Beyazal
    Tumkaya, Levent
    Yilmaz, Adnan
    Coskun, Zerrin Ozergin
    Celiker, Metin
    Oghan, Fatih
    Mercantepe, Tolga
    Terzi, Suat
    Dursun, Engin
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2018, 275 (06) : 1641 - 1647
  • [35] Guideline to Use Gadolinium-Based Contrast Agents at Kyoto University Hospital
    Miki, Yukio
    Isoda, Hiroyoshi
    Togashi, Kaori
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2009, 30 (06) : 1364 - 1365
  • [36] Impact of gadolinium-based contrast agents on the growth of fish cells lines
    Parant, M.
    Sohm, B.
    Flayac, J.
    Perrat, E.
    Chuburu, F.
    Cadiou, C.
    Rosin, C.
    Cossu-Leguille, C.
    ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY, 2019, 182
  • [37] Risks and Options With Gadolinium-Based Contrast Agents in Patients With CKD: A Review
    Rudnick, Michael R.
    Wahba, Ihab M.
    Leonberg-Yoo, Amanda K.
    Miskulin, Dana
    Litt, Harold, I
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2021, 77 (04) : 517 - 528
  • [38] Gadolinium-based contrast agents - what is the evidence for 'gadolinium deposition disease' and the use of chelation therapy?
    Layne, Kerry A.
    Wood, David M.
    Dargan, Paul, I
    CLINICAL TOXICOLOGY, 2020, 58 (03) : 151 - 160
  • [39] Spatially resolved quantification of gadolinium deposited in the brain of a patient treated with gadolinium-based contrast agents
    Fingerhut, Stefanie
    Niehoff, Arm-Christin
    Sperling, Michael
    Jeibmann, Astrid
    Paulus, Werner
    Niederstadt, Thomas
    Allkemper, Thomas
    Heindel, Walter
    Holling, Markus
    Karst, Uwe
    JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY, 2018, 45 : 125 - 130
  • [40] Differences in hypersensitivity reactions and gadolinium deposition disease/symptoms associated with gadolinium exposure to gadolinium-based contrast agents: new insights based on global databases VigiBase, FAERS, and IQVIA-MIDAS
    Qu, Han
    Li, Wenjing
    Wu, Zhenghua
    Wang, Yuanyuan
    Feng, Tingting
    Li, Nianyun
    Qi, Chendong
    Li, Xiang
    Wei, Taishan
    Fan, Guorong
    Lou, Yuefen
    BMC MEDICINE, 2024, 22 (01):
12345